In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature.
about
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transitionMass-spectrometric identification and relative quantification of N-linked cell surface glycoproteinsS-layer, surface-accessible, and concanavalin A binding proteins of Methanosarcina acetivorans and Methanosarcina mazei(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapiesGlobal analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNFα expression.Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryoQuantity and accessibility for specific targeting of receptors in tumours.Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium.Radiation-guided gene therapy of cancer.Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.Ionizing radiation reduces ADAM10 expression in brain microvascular endothelial cells undergoing stress-induced senescence.Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies.Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues.Aberrant glycosylation and localization of polycystin-1 cause polycystic kidney in an AQP11 knockout model.Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapiesProteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues.Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma.Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritisTargeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.Thymic emigration revisitedThe proteomics big challenge for biomarkers and new drug-targets discovery.Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in DrosophilaInhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.Targeting and imaging signature caveolar molecules in lungs.Solid-phase extraction and purification of membrane proteins using a UV-modified PMMA microfluidic bioaffinity μSPE device.Protein and peptide fractionation, enrichment and depletion: tools for the complex proteome.Membrane proteomics by high performance liquid chromatography-tandem mass spectrometry: Analytical approaches and challenges.Uriniferous tubule: structural and functional organization.Improved surfaceome coverage with a label-free nonaffinity-purified workflow.Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia.Tumor angiogenesis revisited: Regulators and clinical implications.Use of colloidal silica-beads for the isolation of cell-surface proteins for mass spectrometry-based proteomicsLow-Cell-Number Epigenome Profiling Aids the Study of Lens Aging and Hematopoiesis.An anti vimentin antibody promotes tube formation.Protein biotinylation.An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.
P2860
Q24310051-CB402AB4-EFFB-4DBC-B1D3-3AAEA6FF24D1Q24313398-B4F77BD3-7BBD-45FE-84D6-E92A00A42FEAQ24646321-F9DBC281-EF4B-4868-A96F-2758667D4E08Q28488869-5E276507-A56D-4FDD-858F-FFB77A8FF578Q30356392-2F381BCD-71FE-4A6D-A5AA-C81146DBBAF7Q30542280-0B379212-2E53-4CC6-B1C3-27E7E9DDC8EDQ30580276-5E4812F8-44F7-4DAF-A4B9-1457F7012F33Q30843102-B705BD82-F187-4264-8889-00C2B09846E3Q33251692-36F56D68-2713-42D1-9897-D4FC4814CF7BQ33309341-C501F335-7568-4623-B3B3-AD59E7DAD6ADQ33648934-62041D57-DCE8-4C1F-ACAE-B50FED6C8323Q33657479-CD38CD6A-1298-4013-9667-A4F48337AB0DQ33697011-DFB5A340-8BEE-4932-9783-9ED46C34241DQ34551892-7E9CAA0C-E745-49C1-8D0C-5A67237944F9Q34568735-CCB3FA2B-3326-4170-B24C-4EE35DCEC919Q34689078-5D82D9A5-2D2D-4C7A-B1A6-2C5750B6E52EQ34756337-A990E640-6C49-4231-A648-49124CE66529Q34897576-E245113E-98F6-4E2B-A9CD-47791C573B30Q35043619-ED0B1B66-7C3C-4782-A749-C7A4F2334260Q35139933-FF45A2A8-C02F-415D-8B20-7A949B50512DQ35431733-D4D552D4-ABCC-4401-8E2F-C14360314ABDQ35769069-FC8D9CB8-0DCE-4960-B9C9-B3DA0771EA51Q36175689-64B720B4-9607-40AC-A52E-03C2A4BE965BQ36229138-68F14814-AAE3-4F70-867D-1B2EF86F086BQ36432402-D11B238D-8B04-423C-8B42-3B6C0ED59362Q36908426-C6924590-CABD-482E-A1AE-5A69E92345CFQ37124501-A5DF0FB0-51F4-4287-AF9E-00AD4A8CDCDDQ37318182-C6E23E26-B00E-4716-8DD8-60D199259217Q37673018-84C4EEDA-7F3B-4B2C-AA64-90A1528B3E16Q37829409-B029EA38-76F1-4286-913C-1C73C826169CQ38057716-8F327484-9329-448D-8435-20FAD20D5513Q38130285-645D51BE-FD69-49C8-8706-E7896BA6B72AQ38719780-5DEBCCD8-F105-48AE-B2BA-AA540A6DACE0Q39100229-5083EE7F-CA38-412B-AA6E-965E3871F007Q39393740-B25C4450-8828-46CC-A05C-EC93F62B2BDCQ42045318-4D06864A-D8B7-423B-8F12-6CD31D5C5E67Q42149226-9DE991BB-FD92-4F1A-BBC4-275F9144B69BQ42199453-7C35ABBB-0FF1-4212-9A3D-FB41F7BE07AAQ43098793-7C3D6994-BD67-4E77-8C60-8D0E9EC8A52DQ45869295-E5BA4F97-34D2-4C8D-9780-6758CFDCC458
P2860
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
In vivo protein biotinylation ...... cessible from the vasculature.
@en
In vivo protein biotinylation ...... cessible from the vasculature.
@nl
type
label
In vivo protein biotinylation ...... cessible from the vasculature.
@en
In vivo protein biotinylation ...... cessible from the vasculature.
@nl
prefLabel
In vivo protein biotinylation ...... cessible from the vasculature.
@en
In vivo protein biotinylation ...... cessible from the vasculature.
@nl
P2093
P2860
P50
P356
P1433
P1476
In vivo protein biotinylation ...... cessible from the vasculature.
@en
P2093
Anna Ettorre
Brigitte Kaissling
Jascha-N Rybak
P2860
P2888
P304
P356
10.1038/NMETH745
P577
2005-03-23T00:00:00Z